7 months ago
APLT
AnalystsBrian AbrahamsBrian Abrahams's Stock Forecasts
AnalystsBrian Abrahams
Analyst Ranking
Bottom 4%
#4756 out of 4906 analysts
Average Return
-3.14%
Win Rate
41%105 out of 256
Risk vs Reward
Poor
Good
Brian Abrahams's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
89bio IncETNB | +558.80% | $2.67 | $17.59 | 2022-05-11 - 2023-05-11 | Buy |
Pliant Therapeutics IncPLRX | +382.01% | $4.67 | $22.51 | 2022-05-09 - 2023-05-09 | Buy |
Ambrx Biopharma IncAMAM | +233.33% | $8.40 | $28.00 | 2023-10-22 - 2024-03-06 | Buy |
Mind Medicine IncMNMD | +222.26% | $3.01 | $9.70 | 2023-03-09 - 2024-03-08 | Buy |
Ambrx Biopharma IncAMAM | +210.77% | $9.01 | $28.00 | 2023-11-13 - 2024-03-06 | Buy |
Brian Abrahams Analyst Color
Get additional color on Brian Abrahams's coverage of popular stocks
a year ago
MNMD
Brian Abrahams's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Moonlake ImmunotherapeuticsMLTX | 2 | Buy | $67.00 | +51.55% | Reiterates | 13 days ago |
Neurocrine Biosciences IncNBIX | 19 | Buy | $145.00 | +16.57% | Reiterates | 14 days ago |
Regeneron Pharmaceuticals IncREGN | 32 | Buy | $943.00 | +78.18% | Reiterates | 20 days ago |
Contineum Therapeutics IncCTNM | 5 | Buy | $31.00 | +599.77% | Reiterates | a month ago |
Aardvark Therapeutics IncAARD | 3 | Buy | $20.00 | +86.22% | Maintains | a month ago |
Applied Therapeutics IncAPLT | 6 | Hold | $1.50 | +323.73% | Reiterates | a month ago |
Karyopharm Therapeutics IncKPTI | 11 | Buy | $33.00 | +651.71% | Maintains | a month ago |
Xenon Pharmaceuticals IncXENE | 14 | Buy | $55.00 | +67.89% | Maintains | a month ago |
Sarepta Therapeutics IncSRPT | 30 | Hold | $58.00 | +60.31% | Maintains | a month ago |
Ptc Therapeutics IncPTCT | 16 | Buy | $58.00 | +13.15% | Maintains | a month ago |
Corbus Pharmaceuticals Holdings IncCRBP | 7 | Buy | $58.00 | +556.85% | Maintains | a month ago |
Vertex Pharmaceuticals IncVRTX | 51 | Hold | $423.00 | -7.12% | Maintains | a month ago |
Biocryst Pharmaceuticals IncBCRX | 14 | Buy | $13.00 | +25.36% | Reiterates | a month ago |
Biogen IncBIIB | 34 | Buy | $205.00 | +56.91% | Maintains | a month ago |
Incyte CorpINCY | 20 | Hold | $67.00 | -1.11% | Maintains | 2 months ago |
Legend Biotech CorpLEGN | 1 | Buy | $84.00 | +128.07% | Reiterates | 2 months ago |
Gh Research PLCGHRS | 1 | Buy | $31.00 | +142.95% | Initiates Coverage On | 3 months ago |
Pliant Therapeutics IncPLRX | 13 | Hold | $3.00 | +117.39% | Maintains | 3 months ago |
Neumora Therapeutics IncNMRA | 6 | Hold | $4.00 | +373.37% | Reiterates | 3 months ago |
Prothena Corp Public Ltd CoPRTA | 10 | Hold | $20.00 | +293.70% | Maintains | 4 months ago |
Gilead Sciences IncGILD | 29 | Hold | $90.00 | -18.17% | Maintains | 4 months ago |
Axsome Therapeutics IncAXSM | 2 | Buy | $143.00 | +37.37% | Maintains | 4 months ago |
Newamsterdam Pharma Co NvNAMS | 1 | Buy | $40.00 | +97.92% | Reiterates | 5 months ago |
Intra Cellular Therapies IncITCI | 17 | Hold | $132.00 | +0.10% | Downgrades | 5 months ago |
Igm Biosciences IncIGMS | 15 | Hold | $1.50 | +23.97% | Downgrades | 5 months ago |
Hookipa Pharma IncHOOK | 11 | Hold | $2.00 | +40.85% | Downgrades | 6 months ago |
Sage Therapeutics IncSAGE | 19 | Hold | $4.00 | -40.30% | Upgrades | 7 months ago |
Galapagos NvGLPG | 10 | Hold | $30.00 | +4.31% | Maintains | 7 months ago |
Marinus Pharmaceuticals IncMRNS | 8 | Hold | $1.00 | +81.82% | Maintains | 8 months ago |
89bio IncETNB | 13 | Hold | $12.00 | +15.27% | Maintains | 10 months ago |
Mind Medicine IncMNMD | 9 | Buy | $22.00 | N/A | Reiterates | a year ago |
Ambrx Biopharma IncAMAM | 3 | Buy | $32.00 | N/A | Maintains | 2 years ago |
Karuna Therapeutics IncKRTX | 7 | Buy | $225.00 | N/A | Maintains | 2 years ago |
Enanta Pharmaceuticals IncENTA | 14 | Hold | $15.00 | N/A | Maintains | 2 years ago |
Intercept Pharmaceuticals IncICPT | 11 | Hold | $19.00 | N/A | Maintains | 2 years ago |
Atai Life Sciences NvATAI | 3 | Hold | $9.00 | N/A | Maintains | 3 years ago |
Merus NvMRUS | 3 | Hold | $33.00 | N/A | Maintains | 4 years ago |
Constellation Pharmaceuticals IncCNST | 1 | Hold | $34.00 | N/A | Downgrades | 4 years ago |
Metacrine IncMTCR | 1 | Buy | $25.00 | N/A | Initiates Coverage On | 5 years ago |
Neubase Therapeutics IncNBSE | 1 | Buy | $320.00 | N/A | Initiates Coverage On | 5 years ago |
Celgene CorpCELG | 2 | Buy | $118.00 | N/A | Downgrades | 7 years ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Strong Buy | N/A | N/A | Upgrades | 8 years ago |
Epizyme IncEPZM | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Alder Biopharmaceuticals IncALDR | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 8 years ago |
Immune Design CorpIMDZ | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 8 years ago |
Avexis IncAVXS | 1 | Hold | $92.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.